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Summary 
Interleukin 10 (IL-10) and viral Ibl0 (v-IL-10) strongly reduced antigen-specific proliferation of 
human T cells and CD4 + T  cell clones when monocytes were used as antigen-presenting cells. 
In contrast, IL-10 and v-Ibl0 did not affect the proliferative responses to antigens presented by 
autologous Epstein-Barr virus-lymphoblastoid cell line (EBV-LCL). Inhibition of antigen-specific 
T  cell responses was associated with downregulation of constitutive, as well as interferon 3'- 
or Ib4-induced, class II MHC expression on monocytes by IL-10 and v-Ibl0,  resulting in the 
reduction in antigen-presenting capacity of these ceUs. In contrast, IL-10 and v-Ibl0 had no effect 
on class II major histocompatibility complex (MHC) expression on EBV-LCL. The reduced antigen- 
presenting capacity of monocytes correlated with a decreased capacity to mobilize intracellular 
Ca 2  + in the responder T cell clones. The diminished antigen-presenting capacities of monocytes 
were not due to inhibitory effects of II.-10 and v-Ibl0 on antigen processing, since the proliferative 
T cell responses to antigenic peptides, which did not require processing, were equaUy well inhibited. 
Furthermore,  the inhibitory effects of Ibl0 and v-IL-10 on antigen-specific proliferative T  cell 
responses could not be neutralized by exogenous Ib2 or Ib4. Although IL-10 and v-IL-10 suppressed 
IL-lc~, IL-1B, tumor necrosis factor ot (TNF-c~), and IL-6 production by monocytes, it was excluded 
that these cytokines played a role in antigen-specific T  cell proliferation, since normal antigen- 
specific responses were observed in the presence of neutralizing anti-Ibl, -IL-6, and -TNF-tx mAbs. 
Furthermore, addition of saturating concentrations of IL-lot, IL-I~, IL-6, and TNF-o~ to the cultures 
had no effect on the reduced proliferative T  cell responses in the presence of Ibl0,  or v-Ibl0. 
Collectively, our data indicate that IL-10 and v-IL-10 can completely prevent antigen-specific T 
cell  proliferation  by  inhibition  of  the  antigen-presenting  capacity  of  monocytes  through 
downregulation of class  II MHC  antigens on monocytes. 
M 
urine  IL-10  (m-IL-10) 1 cytokine  synthesis  inhibitory 
factor (CSIF) is produced by Th2 cells and inhibits 
the synthesis of cytokines, particularly of IFN-y,  by Thl, 
but not Th2 cells (1).  This inhibitory activity on cytokine 
production by IL-IO was found to be indirect and required 
the presence of APC (1, 2). In addition, it was demonstrated 
that cytokine production by Thl clones was affected only 
when macrophages, but not purified conventional or Lyl + 
1  Abbreviations used in this paper: CSIF, cytokine synthesis inhibitory factor; 
FMF, flow microfluorimetry;  hsp, heat shock protein;  m, murine; TT, 
tetanus  toxoid; v, viral. 
B cells,  were used as APC (2).  It was shown that m-Ibl0 
has multiple biological activities. II.,10 has mast cell growth 
factor activity in combination with IL-3 and/or Ib4 (3), and 
T cell growth factor activity on mature and immature mouse 
thymocytes in the presence of Ib2 and IL-4 (4). In addition, 
m-Ibl0 increased the expression of class  II MHC antigens 
on small murine splenic B cells and enhanced the viability 
of these cells (5). Furthermore, m-Ibl0 was shown to be pro- 
duced by murine Ly-1 + B ceils and B cell lymphomas and 
may act as an autocrine growth factor for these cells (6). 
Recently, the cDNA encoding for human Ibl0 was cloned 
from a cDNA library made from a tetanus toxin (TT)-specific 
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activation, including II.-2, IFN-% II.-4, and 11:5, indicating 
that this clone does not fit the Thl or Th2 subsets (7). Human 
I1.-10 and m-IL,10 exhibit extensive sequence homology  to 
a previously uncharacterized open reading frame in the EBV 
genome, BCP, F-1 (7, 8). It was shown that both I1:10 and 
the protein product of BCKF-1, designated viral-I1:10 (v-Ib 
10), exhibited cytokine synthesis inhibitory activity on antigen- 
specific mouse T cell clones and human PBMC activated by 
antigen and macrophages or PHA and anti-CD3 mAbs, respec- 
tively  (7,  9).  However,  v-Ibl0  had little murine mast cell 
stimulatory activity or thymocyte growth factor activity, and 
it did not affect class II MHC expression on mouse splenic 
B  cells  (3,  5). 
I1:10 affected cytokine synthesis of murine Thl clones, but 
not that of Th2 clones,  and the effects of I1:10 on murine 
Th0 clones, which are able to produce II.-2,  II.-4, II.-5,  and 
IFN-3' (10), have not yet been evaluated. Human CD4 + T 
cell clones generally do not display the strict Thl and Th2 
lymphokine production profiles observed for murine CD4 + 
T cell clones (11, 12), and are, in this aspect, more comparable 
to murine Th0 cell clones. However, recently we have shown 
that CD4 + T  cell clones specific for the house dust mite-de- 
rived allergen Der p  I isolated from atopic patients produce 
very high quantities of 1I:4 and I1:5, whereas the levels of 
IFN-y and I1-2 production varied from low to normal (Yssel 
et al., manuscript submitted for publication). On the other 
hand, CD4 + T  cell clones specific for the 65-kD heat shock 
protein (hsp) ofMycobacterium leprae (M. leprae) had a "Thl- 
like" lymphokine profile,  since these clones produced high 
levels of IFN-'y and very low, or sometimes .even undetect- 
able,  levels of I1:4 and 11:5  (13). 
In the present study,  the effects of I1:10 and v-Ibl0  on 
antigen-specific  human T  cell responses were investigated. 
It was shown that  I1:10 and v-I1:10  strongly blocked  the 
antigen-specific  proliferative responses  of both  T  cells  and 
CD4 + Thl- or Th2-1ike T cell clones. The inhibitory effects 
on antigen-specific T  cell proliferation  were only observed 
when monocytes, but not when EBV-LCL were used as APC. 
In addition,  it is shown that Ibl0  and v-ILl0 have strong 
downregnlatory effects on both constitutive and I1:4- or IFN- 
"y-induced class II MHC expression on monocytes, indicating 
that the strongly reduced proliferative T  cell responses to- 
wards antigens are due to inhibition of antigen-presenting 
capacity of monocytes  through downregnlation  of class  II 
MHC  antigens  on these  cells. 
Materials  and Methods 
Cells and Reagents.  The TT-specific T cell clone 827 (14), the 
T cell clones NP12,  NP14,  and NP44, which are specific for the 
major allergen in house dust, Derp I (Yssd et al., manuscript sub- 
mitted for publication), and the 65-kD M. leprae hsp-specific T cell 
clones HY06, Kp1511, R2F10, and CAAp1515 (13, 15) have all 
been described previously. T cell clones (2  x  los/m1) were stimu- 
lated  at  2-wk  intervals  by a  feeder  cell mixture consisting of 
10fire1 irradiated (4,000  tad) allogeneic  PBL,  los/ml irradiated 
(5,000 tad) cells of the EBV-transformed B cell line (EBV-LCL)  JY, 
and 0.1 #g/ml purified PHA (Wellcome Diagnostics, Beckenham, 
Kent, UK) as described  (14) and expanded  by addition of riD2. 
The EBV-LCL HSY, which was established from the same donor 
as T cell clones 827 and HY06 (14), NPR, which was derived from 
the same donor as T cell clones NP12, NP14, and NP44 (Yssel et 
al., manuscript submitted for publication), and PZB (15), which 
was HLA-DR identical  to the tuberculoid leprosy patieut from 
whom the T  cell clones Rp1511 and R2F10 were derived,  have 
been described. T cell clones and EBV-LCL were cultured in Yssel's 
medium (14) supplemented with 1% human AB + serum. TT was 
generously provided by Dr. Bizzini (Institute Pasteur, Paris, France). 
The Derla I cDNA clone was kindly provided by Dr. W. Thomas 
(Princess Margaret Hospital, Perth, Australia). Recombinant Der 
p  I  antigen was expressed  in Escherichia coil and purified (16). 
M. leprae antigen (CD104) was a kind gift of Dr. R. J. W. Rees 
(London, UK). The Der p 1-specific peptide (amino acids 89-117) 
and M. leprae 65-kD hsp peptides (amino acids 3-13 and 418-427) 
were made by solid phase peptide synthesis and checked by analyt- 
ical reverse phase HPLC and amino acid analysis (17). M. leprae- 
specific peptides  were kindly provided by Dr.  D.  C.  Anderson 
(University of Washington, Seattle, WA). 
Recombinant IL-10 and v-IL-10 were expressed in E. coli and 
purified (16). Purified human r-IL-4 and IFN-y were provided by 
Schering-Plough Research (Bloomfield, NJ). The neutralizing mAb 
19F1 recognizing both h-II.d0 and v-IIA0 has been described (J. 
Abrams et al., manuscript in preparation). 
Isolation and Culture of Human Monocytes.  Human peripheral 
blood monocytes were isolated from 500-ml blood samples from 
normal donors as described previously (18, 19). The monocyte prep- 
aration was over >95%  pure,  as judged by nonspecific esterase 
staining,  and contained >98% viable cells. Monocytes were cul- 
tured in Yssel's medium (14) containing HSA supplemented with 
1%  pooled  heat-inactivated  human  AB +  serum.  This  culture 
medium was endotoxin free as determined by the Limulus amebo- 
cyte lysate assay (< 0.2 ng/ml endotoxin). The monocytes were 
cultured at a concentration of 4  x  10  ~ cells/ml in teflon bags 
(Jansen MNL, St. Niklaas, Belgium) and, where indicated, IFN-3, 
(100 U/ml), ID4 (100 U/ml), or TT (0.5 #g/ml) was added. 
Proliferation Assays.  Cloned T cells were used 9-12 d after stim- 
ulation with feeder cells. T  cells (2  x  104 cells/well  were in- 
cubated with irradiated (5,000 rad) autologous EBV-LCL (2  x  104 
cells/well) or HLA-DR-matched human monocytes (104/we11) in 
the presence of antigen or antigenic peptides in 200/zl in round- 
bottomed  (Linbro;  Flow  Laboratories,  McLean,  VA)  or  flat- 
bottomed plates (Falcon; Becton Dickinson & Co., Lincoln Park, 
NJ), respectively. TT was added at a concentration of 0.5 #g/ml, 
M. leprae antigen (CD104) at 1/zg/ml, peptide amino acids 3-13 
or peptide amino acids 418-427  of 65-kDa M.  leprae hsp at 0.5 
/zg/ml, Derp I and the Derp 1-derived peptide 89-117 at concen- 
trations ranging from 10 to 0.01 #g/mE Cells were incubated for 
72 h at 37~  and 5% CO2, pulsed with [3H]TdK for 4 h, and 
harvested  as described previously (14). The results  are expressed 
as cpm of [3H]TdR incorporation  and represent the mean of tripli- 
cate cultures. 
Immunofluorescence Analysis.  Cells  (10  s) were incubated in V-bot- 
tomed microtiter plates (Flow Laboratories) with 10 #1 of purified 
mAb (1 mg/ml) for 30 rain at 4~  After two washes with PBS 
containing 0.02 mM sodium azide and 1% BSA (Sigma Chemical 
Co., St. Louis, MO), the cells were incubated with 1:40 dilution 
of FITC-labeled  F(ab')2 fragments of goat anti-mouse antibody 
(Tago, Inc., Burlingame, CA) for 30 min at 4~  After three addi- 
tional washes,  the labeled  cell  samples  were  analyzed  by flow 
microfluorimetry (FMF) on a FACScan  |  (Becton Dickinson & Co., 
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DP/DQ) (20), Q5/13 HLA-DK/DP (21), SPV-L3 (HLA-DQ) (14), 
and anti-CD3  (SPV-T3b) (14) were described previously). 
Ca 2§ Flux Measurements.  T Cells at 107/ml were loaded with 
Indo-1 by incubation  with its acetoxymethyl  ester (Molecular  Probes, 
Junction City, OK) at a concentration of 1 #M for 45 rain at 37~ 
Cells were washed once and resuspended in flesh medium at 106 
ceUs/ml and stored at room temperature in the dark until tested. 
Calcium  levels  were measured  by FMF with a FACStar  |  plus (Becton 
Dickinson & Co.) equipped with a Coherent Innova 90 argon ion 
laser emitting 200 mW at 351/364 nm. Violet fluorescence  emis- 
sion (Ca  z+ bound Indo-1) was detected through a 20-nm band 
pass 405-nm falter  (Omega Optical, Brattleboro, VT). Blue fluores- 
cence emission (flee Indo-1) was  measured through a  22-nm 
bandpass 485-nm filter (Omega Optical) after separation  with 50:50 
beam splitter. Cells  were analyzed  at 37~  at typical  rates ofg00 cells. 
Results 
h-ILlO and v-ILlO Inhibit Antigen-specific  Proliferation of T 
Cells.  To determine the effect of Ibl0 on antigen-specific 
proliferation of human T cells, purified T cells obtained from 
donors immunized with TT were stimulated with TT and 
autologous purified monocytes. In Fig.  1, it is shown that 
both IL-10 and v-Ibl0 inhibited TT-specific proliferative re- 
sponses of the T cells in a dose-dependent fashion. Significant 
inhibitory effects were already observed at Ibl0 concentra- 
tions of 10 U/ml, whereas maximal inhibition was obtained 
at 100 U/m1. These results indicate that specific proliferative 
responses  of human T  cells to soluble antigen are reduced 
by IF10 and v-IL-10 when monocytes are used as APC. Fur- 
thermore, it is shown in Table 1 that preincubation of the 
monocytes for 24 h with IL-10 (100 U/m1) or v-IL-10 (100 
U/ml), followed by incubation of these cells in the presence 
of purified T ceils and TT (in the absence of IF10), resulted 
in 50% reduction in the proliferative responses, as compared 
to the TT-specific proliferative responses of these T cells when 
cocultured with monocytes preincubated in medium alone. 
Addition of IL-10 or v-IL-10 to the cultures of T  cells, TT, 
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Figure 1.  The effects  of Ibl0 and v-IL-10  on the proliferative  responses 
of peripheral blood T cells to TT presented by autologous  monocytes. 
Lymphocytes  (5 x 104/well)  and monocytes  (2 x 104/well)  were isolated 
by centrifugal  elutriation  and cultured  in the presence of increasing con- 
centrations of Ibl0 and v-lbl0 for 72 h. 
Table  1.  Tetanus Toxoid-specific Proliferative Responses of 
Peripheral Blood T  Cells upon Culture with Autologous 
Monocytes, Preincubated with IL- I O and v-IL-10 
[3H]TdK incorporation 
Culture condition  -  + IL-10  + v-IL-10 
cpm  ￿  10 -3 
T cells  3.4  1.4  1.3 
T cells +  monocytes  29.1  13.5  12.9 
T cells +  monocytes 
(preincubated in medium)  49.5  14.2  13.9 
T cells +  monocytes 
(preincubated with IL-10)  23.4  6.1  6.8 
T cells +  monocytes 
(preincubated with v-IL-10)  22.8  5.6  7.1 
Peripheral blood T cells and monocytes  were isolated  by centrifugal  dutri- 
ation and cultured in the absence or presence of IL-10 (100 U/ml) and 
v-IL-10 (100 U/ml). Monocytes  (2 x  104/well)  were added directly  to 
the T cells (5  x  104/well), or after  preincubation for 24 h in medium, 
IL-10 (100 U/ml),  or v-IL-10 (100 U/ml).  TT  was added at  0.5 
#g/ml).The SD was <10% in all tests. 
and monocytes preincubated with Ibl0 or v-II.-10 abolished 
the TT-specific proliferative responses  of purified T  cells al- 
most completely. These results indicate that ILl0 primarily 
acts  on the antigen-presenting capacity of monocytes. 
11_,10 and v-ILlO Reduce Proliferative Responses of Antigen- 
specific T  Cell Clones.  IL-10  and v-IL-10 also inhibited in a 
dose-dependent way the proliferative responses  of the TT- 
specific T  cell clone 827,  the Der p  I-specific T  cell clone 
NP14, and the T cell clone HY06, which is specific for the 
antigenic peptide 3-13  of the 65-kD M.  leprae hsp, when 
monocytes were used as APC. As shown in Fig. 2, 10 U/ml 
of II.-10 or v-Ibl0 was sufficient  to reduce antigen-specific 
responses by 50-70%, and maximal inhibition was observed 
at 100 U/ml. However, 11.-10 and v-ILl0 did not affect antigen- 
specific  proliferative responses  of these  and  several other 
antigen-specific  CD4 + T cell clones when autologous EBV- 
LCL were used as APC. The anti-ILl0 mAb 19F1 completely 
neutralized the reduced responsiveness  observed in the pres- 
ence of ILl0, demonstrating the specificity of the inhibition 
(Table 2).  II.-10 and v-IL-10 also inhibited the proliferative 
responses towards antigenic peptides that do not require an- 
tigen processing as shown (Fig.  1, Table 2).  The prolifera- 
tion of the Der p  I-specific T  cell clones NP12, NP14, and 
NP44 in response to both the whole Der p  I  and the Der 
p I-derived peptide 89-117 was strongly reduced by II:10 and 
v-ILl0. Similar results were obtained with T cell clone Rp1511, 
which is specific for the 65-kD hsp ofM. leprae. Proliferation 
of this clone in response to both the whole M. leprae antigen, 
or the 65-kD hsp derived peptide 3-13 is blocked for 90% 
by IL-10 (100 U/ml) and v-Ibl0 (100 U/ml). The prolifera- 
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Figure 2.  The effects  of II.-10 and v-IL-10  on the proliferative  responses 
of CD4 + T cell clones to antigens presented  by HLA-DK-matched  mono- 
cytes. T cell clones (2  x  104/well) and HLA-DK-matched  monocytes 
(104/well) were cultured for 72 h in the presence of increasing concen- 
trations of IL-10 or v-IL-10. (A) TT-specific  T cell clone 827 and HLA- 
DR3 + monocytes. (B) Der p I-specific T cell clone NP14 and HLA- 
DRwll §  monocytes. (C) M.  teprae-spedfic T  cell clone HY06 and 
HLA-DR3  + monocytes. 
Figure 3.  Proliferative  responses of the Derp I-specific  CD4 + T cell 
clones NP14 and NP44 to different  concentrations  of antigen presented 
by HLA-DR-matched  monocytes  in the presence  of II..10 and v-IL-10. T 
cell clones (2  x  104/well)  NP-14 (.4) and NP-44 (B) and HLA-DRw11 
monocytes (104/well) were cultured in the presence  of II.10 (100 U/ml) 
or v-IL-10  (100 U/ml) at 10, 1, 0.1, and 0.01/zg/ml of the Derp I-derived 
peptide 89-117 for 72 h. 
tive responses of the CD4 § T cell clones HY06, CAAp1515, 
and R2F10, which are specific for the 65-kD hsp-derived pep- 
tides 3-13 or 418-427 and were established from different 
donors, were also  strongly inhibited by IL-10 and v-IL-10. 
Again, IL-10 and v-IL-10 had no affect on the antigen-specific 
proliferative responses when the peptides were presented by 
autologous EBV-LCL. 
The Inhibition of T  Cell Proliferation by IL.IO and v-ILlO Is 
Dependent on Antigen Concentration.  In Fig.  3, it is shown 
that the degree of reduction of the proliferative responses of 
the Der p  I-specific T  cell clones NP14 and NP44 by IL-10 
and v-IL-10 depended on the antigen concentration. NP14 
and NP44 activated by the Der p  I-derived peptide 89-117 
at concentrations varying from 0.01 to 10/xg/ml, and mono- 
cytes as APC showed the same degree of proliferation (Fig. 
3).  Although  IL-10 and  v-Ibl0  significantly reduced  the 
proliferative responses at peptide concentrations of 10 #g/ml, 
the reduction of the proliferative responses increased further 
at lower peptide concentrations. More than 90% reduction 
of the proliferative responses was observed when the Der p 
I-derived peptide was used at 0.01/zg/ml, a concentration 
that still resulted in maximal proliferative T  cell responses. 
These results indicate that the reduced proliferation observed 
in the presence of IL-10 is particularly pronounced when the 
antigen concentration becomes more limited. 
IL-IO and v-IL-lO Strongly Downregulate Class II MHC Mem- 
brane Expression on Monocytes but Not on EBVLCL.  The results 
obtained thus far suggest that IL-10 and v-IL-10 reduce the 
effectiveness  of monocytes as APC. Antigen-presenting ca- 
pacity of APC has been shown to depend, among other factors, 
on the density of class II MHC molecules accommodating 
the relevant antigenic peptides (22). Therefore, the effects of 
IL-10 and v-IL-10 on constitutive HLA-DR and HLA-DQ 
expression on monocytes were investigated.  HLA-DK expres- 
sion on human monocytes increases  during culture of these 
cells, even after incubation in teflon culture bags, which pre- 
vents adhesion of the cells (Fig. 4) (23). In Fig. 4, it is fur- 
thermore shown that II.-10 strongly downregulated this in- 
creased HLA-DR expression on human monocytes. IL-10 (100 
U/ml) reduced the constitutive HLA-DR expression by 90% 
after 40 h of culture. These results were confirmed by using 
several anti-class II MHC mAbs, specific for HLA-DK/DP 
or HLA-DK alone (not shown). Dose-response studies indi- 
cated that inhibitory effects on HLA-DR expression were al- 
ready observed at IL-IO concentrations of 1 U/ml. The con- 
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EBV-LCL  in the Presence of 1i.-10 or v-IL-lO 
[3H]TdR. Incorporation 
Monocytes 
EBV-LCL 
Antigen  IL-10 + 
T  cell clone  stimulation  -  v-IL-10  IL-10  calL-10  -  v-IL-10  IL-IO 
cpm  x  10 -3 
827  TT  20.1  4.4  6.1  18  8.3  8.4  8.7 
NP12  r-Der p  I  60.1  15.2  18.5  57.5  30.5  29.4  29.5 
89-117  60.1  16.8  18.5  57.5  65  59  60 
NP14  r-Der p  I  20.5  4.5  4.0  22.1  15.5  16.3  13 
89-117  35.7  2.9  3.5  33.5  12.5  12.9  14.1 
NP44  r-Der p  I  25.9  3.7  3.2  22.9  14.5  12.3  12.5 
89-117  35.1  5.1  5.0  36.2  20.5  21.9  18.7 
RP1511  M.  leprae  79.8  11.4  12.8  ND  ND  ND  ND 
2-12  82.9  9.4  8.9  ND  54.2  52.8  54.3 
HY-06  2-12  22  1.0  1.2  20  8.7  8.1  9.1 
CAAP1515  2-12  9  .7  .5  ND  7  6.2  5 
R2F10  2-12  46  5.8  6  ND  150  146  160 
T cell clones (2  x  104/well) and monocytes (104/well) or autologous EBV-LCL (2  x  104) were cultured in the presence of IL-10 (100 U/ml) or 
v-IL-10 (100 U/ml) for 72 h.  Neutralizing anti-IL-10 mAb 19F1 was added at a concentration of 10 #g/ml. r-Der p I and the Der p l-derived 
peptide 89-117 were added at concentrations of 1/~g/ml.  M. leprae and M. leprae 65-kD hsp-derived  peptide 3-13 were added at 1 and 0.5/~g/ml, 
respectively. The SD was <10%  in all tests. 
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Figure 4.  Effects  of IL-10 on HLA-DR/DP and HLA-DQ expression 
on monocytes. Monocytes (4  x  106/well)  were cultured in the absence 
or presence of 100 U/ml IL-10 in medium (A and B), IL-4 (100 U/ml) 
(C), or IFN-T (100 U/ml), (D) for 40 h and analyzed  for expression of 
(A) HLA-DR/DP (Q5/13), (B) HLA-DQ (SPV-L3), (C) HLA-DR/DP, 
and (/9) HLA-DR/DP. 
919  de Waal Malefyt et al. 
stitutive expression of HLA-DQ, which is much lower than 
that of HLA-DR, was also strongly downregulated by IL-10. 
Identical results on downregulation of class II MHC expres- 
sion were obtained with v-IL-10 (not shown). Interestingly, 
IL-10 and v-IL-10 also strongly blocked the enhanced HLA- 
DR and HLA-DQ expression induced by IL-4 (100 U/ml) 
or IFN-3, (100 U/ml).  The dose-response curves shown in 
Fig. 5 for HLA-DR indicate that IL-10 seems to be more effec- 
tive in counteracting  the class II MHC enhancing effect of 
IFN-3, than that of II.,4. In contrast, IL-IO and v-IL-10 failed 
to affect constitutive HLA-DR and HLA-DQ expression on 
various EBV-LCL,  as shown for NPR in Fig.  6. 
II.,10  Affects the Capacity of Monocytes  to Present Antigens 
as Reflected by Reduced Ca  2+ Fluxes in the T  Cell Clones,  If 
the reduction in class II MHC expression on monocytes by 
IL-IO  accounts  for  the  strongly  reduced  antigen-specific 
proliferative responses, this would imply that we are dealing 
with a reduced capacity to induce T  cell activation.  If this 
conclusion is correct, reduced stimulatory capacity of mono- 
cytes as APC  should be reflected in  reduced  induction  of 
Ca  2  + mobilization in the responding T  cell clones. In Fig. 
7, it is shown that Ca  2  § fluxes induced in T  cell clone 827 
were suppressed by "~70%  when  monocytes preincubated 
with TT and IL-10 were used to activate the T  cell clone. 
Ca  2  + fluxes induced by an anti-CD3 mAb were used as con- A 
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Figure 5.  Effects  of IL-10 on HLA- 
DR/DP and HLA-DQ expression on 
human monocytes cultured in the pres- 
ence of IL-4 or IFN-'y. Monocytes (4 
x  106/weU)  were cultum:l in the pres- 
ence of (A) Ib4 (100 U/m1),  or (B) 
IFN-3' (100 U/ml), and 0, 1, 10, and 
100 U/ml IL-10, and analyzed for ex- 
pression of HLA-DR/DP (Q5/13). 
trois. In the presence of I1,10, but in the absence of mono- 
cytes, no changes were observed in the Ca  2+  fluxes of the 
T cell clone in response to anti-CD3 mAbs. However, when 
monocytes, preincubated with TT in the presence of I1,10, 
were added to the T  cell clones, strong reductions in both 
the plateau levels of the Ca  2+  fluxes and the percentage of 
positive cells were observed, as compared to the Ca  2+ fluxes 
induced by monocytes that were preincubated with TT alone. 
It has to be noted that Ca  2  + fluxes could be measured at the 
earliest 3-4 rain  after addition  of the monocytes to the T 
cells, because a 2-min centrifugation step was required in order 
to establish optimal T  cell/APC contacts. 
Reduced Antigen-specific T Cell Proliferation Induced by 11,10 
and v-I1,I0  Cannot be Neutralized  by Exogenous 11,2 or 11,4. 
The results thus far suggest that the reduced proliferative re- 
sponses of the T cell clones observed in the presence of I1,10 
and v-Ibl0 are related to a reduced capacity of monocytes 
to present antigen, which leads to an incomplete activation 
of the T cell done. Since II.-10 has cytokine synthesis inhibi- 
tory (CSI) activity (de Waal Malefyt et al.,  manuscript  in 
preparation),  the effects of I1.-2 and II.-4 on the inhibition 
of antigen-specific proliferative responses were examined. In 
Fig. 8, it is shown that I1,10 and v-I1,10 inhibited the antigen- 
specific response of T  cell clone 827 to TT with monocytes 
as APC by 85-90%. The addition of increasing amounts of 
I1,2 to these cultures resulted in enhanced proliferative re- 
sponses, both in the presence or absence of I1,10, until a pla- 
teau was reached at concentrations of 1,000 U/ml. Addition 
of I1,2 at concentrations of up to 100 U/ml, which is suf~cient 
to saturate high ai~nity I1,2Rs, had no effect on the inhibi- 
tion  of antigen-spedfic T  cell proliferation  by I1,10.  Even 
at I1,2 concentrations of >1,000 U/ml, still 30-40% inhibi- 
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HLA-DQ  Figure 6.  The effects of IL-10 on 
HLA-DR/DP and HLA-DQ expres- 
sion on EBV-LCL. EBV-LCL NPR (5 
x  105/well) were cultured in the ab- 
sence (A and C), or in the presence (B 
and D) of II.-10 (100 U/ml) and ana- 
lyzed for e=pression  of (A and B) HLA- 
DR (Q5/13) and HLA-DQ (SI~-L3). 
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Figure 7.  Induction of Ca2+fluxes in T  cell clone 827 by anti-CD3 
mAb and to antigen presented by monocytes, preincubated with II.-10. 
IntraceUular Ca  2+ concentrations  were measured in T cell clone 827 in 
response to anti-CD3 mAb, anti-CD3 mAb +  Ibl0 (100 U/ml), mono- 
cytes preincubated with TT (0.5 #g/ml), and monocytes preincubated with 
TT and Ibl0 (100 U/ml). Anti-CD3 mAbs were added at 0 rain. T cells 
and monocytes were centrifuged for 2 rain to establish cell-cell contacts, 
gently resuspended, and analyzed on the FACS  | 
tion was observed. These results indicated that inhibition of 
I1,2 production, due to the CSI activity of II.-10, could only 
partially account for the inhibition of antigen-specific  prolifer- 
ation of T cell clone 827. Furthermore, it is shown in Fig. 
8 that monocytes and high concentrations of IL-2 were able 
to induce proliferation  of the T  cell clones in the absence 
of antigen. These responses were also inhibited by I1,10. How- 
ever, the proliferative responses of T cell clone 827 to Ib2 
in the absence of monocytes were, as expected, not affected 
by 11.-10. Identical results were obtained  with v-I1,10 (not 
shown). Addition of increasing amounts of I1,4 to the T cell 
clone 827 activated by TT and monocytes as APC completely 
failed to affect the antigen-specific proliferative responses, ei- 
ther in the absence or in the presence of IL-10 and v-I1,10 
(not shown). This indicated that Ib4 was not involved in 
the I1,10-mediated inhibition of antigen-specific proliferation 
of this T  cell done. 
Expression of IL-2Rot or I1,2RB  chains of T cell clones 
that were cultured for up to 72 h in the presence of I1,10 
or v-lbl0 was not modulated (not shown). Collectively, these 
data indicate that reduced antigen-presenting capacity  of  mono- 
cytes caused by I1,10-mediated downregulation of class II 
MHC expression leads to incomplete activation of the T cell 
clones that can only be partially rescued by very high con- 
centrations of exogenous I1,2, but not by I1,4. 
Discussion 
Ibl0 and its viral counterpart, v-IL-10, can completely  pre- 
vent the specific proliferative responses of CD4 + T cells and 
CD4 + T  cell clones towards various protein antigens  and 
antigenic peptides. Reduced antigen-specific proliferative re- 
sponses were observed only when monocytes, and not when 
autologous or allogeneic EBV-LCL carrying the appropriate 
restriction elements, were used as APC. These results are in 
line with observations made in murine systems where Horen- 
tino et al. (2) showed that II=10 inhibited IFN-'y production 
by mouse T helper cell clones when monocytes, but not when 
B cells, were used as APC. Interestingly, the reduced respon- 
siveness was partially restored by exogenous II,2, but only 
at very high concentrations of >1,000 U/ml, suggesting that 
the reduced proliferation  observed in the presence of IL-10 
and v-IL-10 under the present culture conditions was not a 
mere consequence of inhibition of endogenous I1.-2 produc- 
tion, due to CSI activity of I1,10 or v-I1,10. This observa- 
tion is compatible with murine studies that have indicated 
that m-I1,10 (CSIF) had only weak inhibitory effects on I1,2 
production by Thl cells after activation by antigen presented 
by maerophages (1). In addition, these studies showed that 
m-IL-10 still suppressed the production of IFN-y by Thl dones 
when these experiments were performed in the presence of 
saturating quantities  of Ib2 (1). Ibl0 and v-Ibl0 also re- 
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Figure 8.  Effects  of IL-2 on the re- 
duced antigen-specific proliferative re- 
sponses of CD4 + T cell clone 827 in- 
duced by II.-10. T cell clone 827 (2  ￿ 
10~/well) was cultured with increasing 
amounts of II.-2 under the following 
conditions:  (I)  with  monocytes 
(104/well) and TT  (0.5  #g/ml);  (2) 
with monocytes,  TT, and ILl0 (100 
U/ml); (3) with monocytes in the ab- 
sence of TT; (4) with monocytes and 
I1.,10 in the absence of TT; (5) with TT 
in the absence of monocytes;  and (6) 
with TT and I1.,10 in the absence of 
m0nocytes. duced the proliferative responses to antigenic peptides, which 
do not require processing (24,  25),  indicating that the in- 
hibitory effects of II:10 and v-Ibl0 are not related to inhibi- 
tion of antigen processing by the monocytes. Comparable 
data were obtained in routine studies that demonstrated that 
m-Ibl0 also reduced cytokine production after activation by 
superantigens that do not require processing (2).  Murine 
studies furthermore indicated that m-IL-10 suppressed lym- 
phokine production by Thl cells (1). Human CD4 + T cell 
clones cannot generally be divided in Thl or Th2 subsets 
(11, 12). However, the Derp I-specific T cell clones have been 
shown to produce very high levels of Ib4 and IL-5 and low 
to normal levels of Ib2 and IFN-% Because of these aberrant 
IL-4/IFN-',/production ratios,  these clones were designated 
as "Th2-1ike" cells (Yssel et al., manuscript submitted for pub- 
lication). In contrast, the M. lelorae-specific T cell clones pro- 
duced unusually high levels of IFN-% and undetectable or 
very low levels of Ib4 and IL-5, and were therefore consid- 
ered to represent "Thl-like" cells (13). Although these clones 
do not fully represent murine Thl or Th2 cells, it is of in- 
terest to note that IL-10 and v-IL-10 inhibited the prolifera- 
tion of both the Der p I- and the M.  leprae-specific  clones 
equally  well. 
IL-10 and v-IL-10 strongly downregulated constitutive class 
II MHC expression on human monocytes. IL-10 and v-IL-10 
not only downregulated constitutive class II MHC expres- 
sion, but also blocked the class II MHC enhancing effects 
of IFN-"/and IL-4 in a dose-dependent fashion.  I1.-10 and 
v-Ibl0 failed to modulate class I MHC expression on mono- 
cytes and did not affect the levels of CDlla, CD11b, CDllc, 
CD18,  CD54  (ICAM-1),  CD58  (LFA-3), CD14,  CD44, 
VLA-4,  VLA-5,  VLA-6,  CD23,  and  CD25  (results  not 
shown).  These results indicate that  the reduction in  the 
antigen-presenting capacity of monocytes is not due to inhi- 
bition of intercellular adhesion molecules that either directly 
(26, 27), or by mediating T cell APC contacts, play an im- 
portant role in T cell activation and proliferation. The obser- 
vation that the APC function of EBV-LCL was not affected 
by II:10 and v-IL-10 tested over a wide concentration range 
and after prolonged incubation times (up to 4 d), together 
with the fact that IL-10 and v-Ibl0 failed to downregulate 
class II MHC expression on these cells, suggested that the 
reduction in antigen-specific proliferative responses of CD4 + 
T cells and T cell clones could be associated with the strong 
reduction in surface class II MHC expression on the mono- 
cytes. Harding & Unanue (28) recently have shown that '~300 
class II MHC-specific antigenic peptides complexes on APC 
representing only 0.1-0.2% of the restricting class II MHC 
molecules were sufficient to induce T cell proliferation.  Their 
studies furthermore indicated that most class II MHC mole- 
cules were not occupied by the antigenic peptide, but prob- 
ably by self or other antigenic peptides (28). Such a very low 
percentage of class II MHC molecules accommodating the 
specific peptides may account for the observation that the 
proliferative responses were reduced by >90%, whereas there 
was still considerable surface class II MHC expression on the 
monocytes. In addition, it was shown recently that antigenic 
peptides need to associate with newly synthesized HLA-DR 
molecules before cell surface expression (29, 30). Recycling 
of class II MHC molecules (31), or association  of peptides 
with "empty" class II MHC molecules expressed on the cell 
surface, do not significantly contribute to the expression of 
immunogenic  class II MHC peptide complexes (29-31). This 
suggests that class II MHC synthesis and cell surface expres- 
sion of new MHC class II/peptide complexes is particularly 
important for antigen presentation. It is possible  that this 
process is downregulated by IL-10. This notion is further sup- 
ported by the observation that reduction of the proliferative 
responses was more pronounced when the antigen concen- 
tration became limiting. From these observations,  it can be 
concluded that IL-10 and v-IL-10 in these culture systems do 
not act as suppressor factors, but that the reduction in antigen- 
specific T cell proliferation in the presence of monocytes as 
APC  merely reflects  a  strong  reduction in  the  antigen- 
presenting capacity of these cells. This contention was com- 
patible with the observations that the [Ca2+]i fluxes were 
strongly reduced when the TT-specific T  cell clones were 
stimulated by monocytes preincubated with TT in the pres- 
ence of IL-10 or v-IL-10 and that neither IL-2-induced prolifer- 
ation nor the expression of IL-Roe and ID2R3 chains on the 
T  cell clones was affected by IIA0 and v-IL-10. 
More recently, we have demonstrated that IL-10 and v-IL- 
10 strongly inhibit the production of IL-lo~, IL-13, II,-6, I1.-8, 
TNF-oe, and granulocyte/macrophage (GM)-CSF (31a). II.~loe, 
IL-13, and also Ib6, TNF-c~ and GM-CSF have been shown 
to have costimulatory effects on antigen-specific T cell prolifer- 
ation (32-35). However, it was excluded that the strong reduc- 
tion in antigen-specific proliferative responses was due to in- 
hibition of the production of these monokines, because reduced 
responsiveness  could  not  be  neutralized  by  addition  of 
saturating concentrations of these monokines. In addition, 
it was demonstrated that under the present culture condi- 
tions, antibodies against these monokines did not decrease 
the antigen-specific proliferative T cell responses (not shown). 
It was also ruled out that II~10 induced the production of 
TGF-~ (36),  or other unknown soluble  suppressor factors 
by monocytes. Supernatants of cultures in which strong reduc- 
tion in T cell proliferation was obtained in the presence of 
monocytes, TT, and IL-10, failed to affect the specific prolifer- 
ative responses of T cell clones induced by TT presented by 
autologous EBV-LCL (not shown). Furthermore, freshly iso- 
lated monocytes added in relatively high concentrations to 
cultures of TT-specific T cell clones, TT, and autologous EBV- 
LCL as APC failed to reduce the proliferative  responses of 
these clones in the presence of IL-10, indicating that IL-10 
did not induce these "bystander" monocytes to release factors 
suppressing antigen-specific T cell proliferation. In addition, 
supernatants of monocytes cultured in the presence or ab- 
sence of IL-10 and tested in the presence of the neutralizing 
anti-IL-10 mAb failed to enhance the TT-specific prolifera- 
tive responses of T cell clones suboptimally activated by TT 
and autologous EBV-LCL. This argues against the idea that 
IL-10 could suppress the production of a putative soluble mono- 
cyte factor, which has costimulatory activity on antigen-specific 
T  cell proliferation. 
Collectively,  our data indicate that both-10 and v-IL-10 
922  Interleukin 10 Inhibits T  Cell Proliferation through downregulation of class II MHC molecules on mono- 
cytes strongly reduce the antigen-presenting capacity of these 
cells, thereby reducing, or preventing, optimal antigen-specific 
proliferative T  cell responses. 
Recently, we have shown that monocytes stimulated by 
LPS produce I1:10. However, I1:10 is produced late (24-36 
h) after activation (31a), whereas I1:1ol, 11-13, II:6, and TNF-ol 
are generally maximally produced after 8-12 h of activation 
(37).  These  kinetics  of I1:10  production  by  monocytes, 
together  with  its  inhibitory effects  on  proinflammatory 
monokine production and its downregulatory effects on class 
II MHC molecules, suggest that I1:10 in an autocrine fashion 
may play a role in damping immune responses. 
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